Published in Neth J Med on January 01, 1976
A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med (1999) 3.11
Functional 'immaturity' of isolated B cells from patients with hypogammaglobulinaemia. Clin Exp Immunol (1980) 1.45
Neutrophil granulation stained with May Grunwald Giemsa or pure Azure B-eosin Y quantified by image analysis. Blut (1989) 1.39
Characteristics of red blood cell populations fractionated with a combination of counterflow centrifugation and Percoll separation. Blood (1992) 1.32
Two immunologically distinct forms of late-onset hypogammaglobulinaemia. Clin Exp Immunol (1981) 1.27
Lymphocyte-stimulation tests and patch tests to carbamazepine hypersensitivity. Clin Exp Immunol (1977) 1.26
The localization of Hodgkin's disease in lymph nodes. A study with immunohistological, enzyme histochemical and rosetting techniques on frozen sections. Int J Cancer (1979) 1.16
Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test. Clin Exp Immunol (1977) 1.10
Observations on abnormal cells in the peripheral blood and spleen in Hodgkin's disease. Br Med J (1972) 1.10
Successful chemotherapy with deoxycoformycin in adult T-cell lymphoma-leukaemia. Br J Haematol (1984) 1.09
The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. Clin Exp Immunol (1985) 1.07
Functional studies on T cells in adult human bone marrow. Clin Exp Immunol (1979) 1.05
Determinants of red blood cell deformability in relation to cell age. Eur J Haematol (1994) 1.01
The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen. Clin Exp Immunol (1989) 1.00
Association of smooth muscle cell tissue factor with caveolae. Blood (1996) 0.97
Suppression of DNA synthesis by Con A-activated human lymphocytes: Stimulation by con A bound to non-T cells unless removed after activation. Clin Exp Immunol (1977) 0.97
Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia. Eur J Clin Microbiol Infect Dis (1995) 0.96
Interleukin-4 inhibits the lipopolysaccharide-induced expression of c-jun and c-fos messenger RNA and activator protein-1 binding activity in human monocytes. Blood (1993) 0.92
The significance of intracytoplasmic proteins in Reed-Sternberg cells. Cancer (1978) 0.91
Curative radiotherapy in Hodgkin's disease: significance of haematogenous dissemination established by examination of peripheral blood and spleen. Br Med J (1972) 0.91
Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate. Br Med J (Clin Res Ed) (1986) 0.90
Basal tissue factor expression in endothelial cell cultures is caused by contaminating smooth muscle cells. Reduction by using chymotrypsin instead of collagenase. Thromb Res (1995) 0.89
Pseudothrombocytopenia due to agglutinins. Am J Clin Pathol (1979) 0.88
Transcriptional and posttranscriptional regulation of the interleukin-4 and interleukin-3 genes in human T cells. Blood (1993) 0.88
Transfection of small numbers of human endothelial cells by electroporation and synthetic amphiphiles. Eur J Vasc Endovasc Surg (1999) 0.87
The heterogeneity of follicular center cell lymphomas. I. Cytohistologic, immunologic, and enzymehistochemical aspects. Cancer (1983) 0.87
The heterogeneity of follicular follicle center cell tumors. II. Clinical follow-up of 30 patients. Cancer (1983) 0.87
Human tonsil B lymphocyte function. I. The proliferative response to Staphylococcus aureus and pokeweed mitogen in relation to surface heavy chains mu and delta. Clin Exp Immunol (1984) 0.86
Immunological responsiveness against two primary antigens in untreated patients with Hodgkin's disease. Eur J Cancer (1975) 0.85
Antibodies to Epstein-Barr virus, cytomegalovirus, and Australia antigen in Hodgkin's disease. Cancer (1974) 0.85
Interferon-gamma enhances the LPS-induced G-CSF gene expression in human adherent monocytes, which is regulated at transcriptional and posttranscriptional levels. Exp Hematol (1993) 0.85
Reproducibility and clinical value of 18F-fluorodeoxyglucose positron emission tomography in recurrent melanoma. Nucl Med Commun (2002) 0.84
Alkaline phosphatase positive lymphomas: a morphologic, immunologic, and enzymehistochemical study. Cancer (1981) 0.83
Efficacy of an anti-CD138 immunotoxin and doxorubicin on drug-resistant and drug-sensitive myeloma cells. Int J Cancer (1999) 0.83
Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia. Blood (1986) 0.83
T-lymphocyte number and function and the course of hepatitis B in hemodialysis patients. Infect Immun (1976) 0.83
Hypothyroidism leads to more small-sized platelets in circulation. Thromb Haemost (1987) 0.82
IL-7 enhances the expression of IL-3 and granulocyte-macrophage-CSF mRNA in activated human T cells by post-transcriptional mechanisms. J Immunol (1993) 0.82
Microbial influences on urinary polyamine excretion. Clin Chim Acta (1989) 0.82
Mass spectrometric identification of isoputreanine, a metabolite of spermidine and/or spermine, in human urine. J Chromatogr (1982) 0.82
Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma. Blood (1989) 0.81
Value of serum S-100B for prediction of distant relapse and survival in stage III B/C melanoma. Anticancer Res (2008) 0.80
In vitro effects of lithium on granulocyte colony formation in normal men, in hematological disorders and in small-cell carcinoma of the lung. Acta Haematol (1983) 0.80
Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate. Transfusion (1997) 0.80
Mass fragmentographic identification of polyamine metabolites in the urine of normal persons and cancer patients, and its relevance to the use of polyamines as tumour markers. J Chromatogr (1985) 0.80
Lymphocytes with parallel tubular structures: morphologically a distinctive subpopulation. Blut (1983) 0.80
Simultaneous expression and regulation of G-CSF and IL-6 mRNA in adherent human monocytes and fibroblasts. Br J Haematol (1991) 0.80
Recovery of murine myelopoiesis after cytostatic reduction by Ara-C. Effect of bacitracin-induced changes in the intestinal microflora and influence of timing. Leuk Res (1991) 0.79
Bispecific monoclonal antibody therapy of B-cell malignancy. Leuk Lymphoma (1995) 0.79
Evidence for transfer of cellular and humoral immunity to cytomegalovirus from donor to recipient in allogeneic bone marrow transplantation. Clin Exp Immunol (1992) 0.79
Interleukin-4 receptor regulation in human monocytic cells. Blood (1994) 0.79
Association of endothelial tissue factor and thrombomodulin with caveolae. Blood (1996) 0.79
Reversible hypogammaglobulinaemia after diphenylhydantoin and hydroxyzine therapy. Neth J Med (1974) 0.79
Tolerance and efficacy of Amphotericin B inhalations for prevention of invasive pulmonary aspergillosis in haematological patients. Eur J Clin Microbiol Infect Dis (1997) 0.79
Rheological properties of blood in Raynaud's phenomenon. Vasa Suppl (1992) 0.78
Simultaneous gas-chromatographic determination of free and acetyl-conjugated polyamines in urine. Clin Chem (1986) 0.78
Long-term treatment with interferon-alpha 2b for severe pruritus in patients with polycythaemia vera. Br J Haematol (1995) 0.78
The value of immunohistochemistry and in situ hybridization in detecting cytomegalovirus in bone marrow transplant recipients. APMIS (1990) 0.78
Plasma spermidine concentrations as early indication of response to therapy in human myeloma. J Clin Pathol (1983) 0.78
Human peripheral blood B cell subpopulations: surface IgD+ cells respond to pokeweed mitogen with plasma cell differentiation. Clin Exp Immunol (1986) 0.78
Differential regulation of M-CSF and IL-6 gene expression in monocytic cells. Br J Haematol (1994) 0.78
Interleukin-4 mRNA and protein in activated human T cells are enhanced by interleukin-7. Exp Hematol (1994) 0.77
Interleukin-4 suppresses the interleukin-3 dependent erythroid colony formation from normal human bone marrow cells. Br J Haematol (1990) 0.77
The effects of IL-1 beta and IL-4 on the proliferation and endogenous secretion of growth factors by acute myeloblastic leukemic cells. Leukemia (1992) 0.77
Hodgkin's disease and herpes viruses. Neth J Med (1976) 0.77
Expression and regulation of IL-4 receptors on human monocytes and acute myeloblastic leukemic cells. Leukemia (1991) 0.77
Texture of white blood cells expressed by the counting densitogram. Cytometry (1981) 0.77
Parallel tubular structures in lymphocytes. I. Occurrence in patients with Hodgkin's Disease. Acta Haematol (1975) 0.77
Effect of intestinal flora modulation by oral polymyxin treatment on hemopoietic stem cell kinetics in mice. Acta Haematol (1986) 0.77
Fc gamma receptors on lymphocytes from normal donors and patients with lymphoproliferative diseases. Influence of incubation conditions. Acta Haematol (1983) 0.76
The supportive effects of IL-7 on eosinophil progenitors from human bone marrow cells can be blocked by anti-IL-5. J Immunol (1992) 0.76
Hodgkin's disease in the spleen. Investigation of Hodgkin foci and areas for the immune response. Virchows Arch B Cell Pathol (1978) 0.76
In vitro evaluation of a high-efficiency leukocyte adherence filter. Ann Hematol (1991) 0.76
Abnormal cells in ther peripheral blood of patients with Hodgkin's disease. I Observation with light microscopy. Br J Haematol (1974) 0.76
G(AnH)MTetra, a naturally occurring 1,6-anhydro muramyl dipeptide, induces granulocyte colony-stimulating factor expression in human monocytes: a molecular analysis. Infect Immun (1994) 0.76
Alpha-interferon for intractable pruritus in polycythaemia vera. Lancet (1991) 0.76
Letter: The spleen in Hodgkin's disease. Lancet (1974) 0.76
The effects of IL-1 and IL-4 on the Epo-independent erythroid progenitor in polycythaemia vera. Br J Haematol (1994) 0.76
Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity. Clin Exp Immunol (1978) 0.76
Sweet's syndrome in myeloid malignancy: a report of two cases. Br J Haematol (1994) 0.76
Prestorage leukocyte depletion is not necessarily required for the prevention of refractoriness to platelet transfusion. Blood (1995) 0.75
Alloantigen-specific T-cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contact. Immunology (1996) 0.75
Changes in T4/T8 ratio over a ten years period related to the factor VIII concentrates used in a group of HIV negative haemophiliacs. Thromb Haemost (1995) 0.75
[Studies of patients with Hodgkin's disease using 75Se-methionine]. Ned Tijdschr Geneeskd (1968) 0.75
Cryosurgery in metastatic malignant melanoma. Panminerva Med (1976) 0.75
The effect of cyclosporine on haematological parameters in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol (1995) 0.75
A commercially available interactive pattern recognition system for the characterization of blood cells: description of the system, extraction and evaluation of simple geometrical parameters of normal white cells. Clin Lab Haematol (1979) 0.75
Relevance of morphometric parameters for the classification of normal white blood cells. Clin Lab Haematol (1982) 0.75
Letter: Phagocytosis in chronic granulomatous disease. Lancet (1975) 0.75
Efficacy and safety of a monoclonal purified factor VIII concentrate: 5-year follow-up in previously treated HIV-negative haemophiliacs. Haemostasis (1996) 0.75
Bacterial infections and thrombocytopenia in chronic idiopathic thrombocytopenic purpura. Acta Haematol (1979) 0.75
Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma. J Clin Lab Immunol (1980) 0.75
Preparation techniques of blood and bone marrow for automated white cell analysis. Microsc Acta Suppl (1980) 0.75
Interleukin-4-mediated inhibition of C-Fos mRNA expression: role of the lipoxygenase directed pathway. Leukemia (1994) 0.75
Recognition of white blood cells with an interactive morphometry system(T.A.S.). Microsc Acta Suppl (1980) 0.75
Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure. Scand J Infect Dis (1994) 0.75